Botulinum Toxin A for the Treatment of Keratoconus
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to associate the use of botulinum toxin type A for patients with
keratoconus to demonstrate that tension eyelid has an important role in disease progression.
Phase:
N/A
Details
Lead Sponsor:
Federal University of São Paulo
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA